During the past decade, Univ. of Cincinnati CRS (2401) conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 16 clinical trials were completed, i.e. on average, 177.8% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Univ. of Cincinnati CRS (2401)" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 21 trials as a collaborator, "Exegi Pharma, LLC" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Univ. of Cincinnati CRS (2401)" are "HIV-1 Infection" (16 trials), "HIV Infections" (3 trials), "HIV Infection" (1 trials), "HIV-1-infection" (1 trials) and "Hepatitis C" (1 trials). Many other conditions were trialed in "Univ. of Cincinnati CRS (2401)" in a lesser frequency.

Most popular intervention types in "Univ. of Cincinnati CRS (2401)" are "Drug" (21 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ritonavir" (3 trials), "Aspirin" (2 trials), "Atazanavir" (2 trials) and "Darunavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Univ. of Cincinnati CRS (2401)" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Univ. of Cincinnati CRS (2401)". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Univ. of Cincinnati CRS (2401), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Univ. of Cincinnati CRS (2401), 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".